A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Condition: Ulcerative Colitis Interventions: Drug: LT-02; Drug: LT-02 Placebo Sponsors: Prometheus Laboratories; Nestlé Health Science Spain; INC Research Recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2016 Category: Research Source Type: clinical trials
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
< b > Condition < /b > : Ulcerative Colitis < br/ > < b > Interventions < /b > : Drug: LT-02; Drug: LT-02 Placebo < br/ > < b > Sponsors < /b > : Prometheus Laboratories; Nestlè Health Science; INC Research < br/ > < b > Recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2016 Category: Research Source Type: clinical trials